ATE456799T1 - Verfahren zum identifizieren von präneoplastischen und neoplastischen stadien in säugern - Google Patents

Verfahren zum identifizieren von präneoplastischen und neoplastischen stadien in säugern

Info

Publication number
ATE456799T1
ATE456799T1 AT00918600T AT00918600T ATE456799T1 AT E456799 T1 ATE456799 T1 AT E456799T1 AT 00918600 T AT00918600 T AT 00918600T AT 00918600 T AT00918600 T AT 00918600T AT E456799 T1 ATE456799 T1 AT E456799T1
Authority
AT
Austria
Prior art keywords
neoplastic
mammals
identifying
preneoplastic
neoplastic stages
Prior art date
Application number
AT00918600T
Other languages
English (en)
Inventor
Michael Slater
Julian Barden
Original Assignee
Biosceptre Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosceptre Int Ltd filed Critical Biosceptre Int Ltd
Application granted granted Critical
Publication of ATE456799T1 publication Critical patent/ATE456799T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/5759—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds localised on the membrane of tumour or cancer cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT00918600T 1999-04-21 2000-04-26 Verfahren zum identifizieren von präneoplastischen und neoplastischen stadien in säugern ATE456799T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP9911A AUPP991199A0 (en) 1999-04-21 1999-04-21 Methods for diagnosing pre-cancerous and cancerous conditions
PCT/AU2000/000363 WO2001006259A1 (en) 1999-04-21 2000-04-26 A method for identifying pre-neoplastic and/or neoplastic states in mammals

Publications (1)

Publication Number Publication Date
ATE456799T1 true ATE456799T1 (de) 2010-02-15

Family

ID=3814111

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00918600T ATE456799T1 (de) 1999-04-21 2000-04-26 Verfahren zum identifizieren von präneoplastischen und neoplastischen stadien in säugern

Country Status (14)

Country Link
US (3) US7183064B1 (de)
EP (1) EP1179183B1 (de)
JP (1) JP4633984B2 (de)
KR (1) KR100819395B1 (de)
CN (1) CN100557445C (de)
AT (1) ATE456799T1 (de)
AU (2) AUPP991199A0 (de)
CA (1) CA2371163A1 (de)
DE (1) DE60043775D1 (de)
DK (1) DK1179183T3 (de)
ES (1) ES2340137T3 (de)
NO (1) NO331018B1 (de)
WO (1) WO2001006259A1 (de)
ZA (1) ZA200108616B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP991199A0 (en) * 1999-04-21 1999-05-13 University Of Sydney, The Methods for diagnosing pre-cancerous and cancerous conditions
AUPR201500A0 (en) * 2000-12-11 2001-01-11 Biosceptre Pty Ltd Methods for identifying pre-neoplastic and neoplastic states in mammals
CA2434490C (en) 2001-01-17 2014-06-03 Intreat Pty Limited Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions
US8067550B2 (en) 2006-10-10 2011-11-29 Biosceptre International Limited Hybridomas producing antibodies against non functional P2X7 receptor
CA2737126C (en) 2007-09-14 2018-05-01 Biosceptre International Limited Novel p2x7 epitopes
AU2013238152B2 (en) * 2007-09-14 2015-09-24 Biosceptre International Limited Purinergic (P2X) receptors in extra-cellular body fluid
NZ583896A (en) 2007-09-14 2011-05-27 Biosceptre Int Ltd Purinergic (p2x) receptors in extra-cellular body fluid
AU2009266430B2 (en) 2008-07-04 2014-08-14 Biosceptre International Limited Anti- P2X7 peptides and epitopes
AU2009329501B2 (en) * 2008-12-19 2015-11-26 Ablynx N.V. Genetic immunization for producing immunoglobulins against cell-associated antigens such as P2X7, CXCR7 or CXCR4
JP5936067B2 (ja) 2009-08-20 2016-06-15 バイオセプター・（オーストラリア）・ピーティーワイ・リミテッド 抗ｐ２ｘ７受容体抗体およびその断片
BR112012015561B1 (pt) 2009-12-24 2019-11-12 Biosceptre International Limited anticorpos dirigidos contra receptores p2x7 oligoméricos não funcionais
WO2012031333A1 (en) 2010-09-10 2012-03-15 Biosceptre International Limited Companion animal treatments
BR112013033974A2 (pt) 2011-07-01 2017-02-14 Biosceptre Int Ltd terapia de combinação
CA2946669A1 (en) * 2014-05-02 2015-11-05 Medimmune Limited Ion channel modulators & uses thereof
AU2016318230B2 (en) 2015-09-11 2020-05-21 Biosceptre (Aust) Pty Ltd Chimeric antigen receptors and uses thereof
CN109862883A (zh) 2016-10-21 2019-06-07 生物权威（英国）有限公司 细胞毒性颗粒

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE920765A1 (en) * 1991-03-12 1992-09-23 Scripps Research Inst Cell surface receptors homologous to coagulation factors v¹and viii
JP3084982B2 (ja) * 1992-11-25 2000-09-04 富士電機株式会社 半導体装置
JPH10501122A (ja) * 1994-05-27 1998-02-03 グラクソ、グループ、リミテッド Ｐ▲下２ｘ▼レセプター（プリノセプターファミリー）
JPH11510393A (ja) * 1995-08-09 1999-09-14 インスティチュート ナショナル ドゥ ラ セント エト ドゥ ラ リサーチェ メディカル 白血病マーカーとしておよび乳癌の予後において有用な単離された核酸分子
EP0907729A1 (de) * 1996-04-30 1999-04-14 Smithkline Beecham Plc Splicevarianten des menschlichen p2x4 rezeptors
US6303338B1 (en) * 1996-08-16 2001-10-16 Human Genome Sciences, Inc. Pancreas-derived plasminogen activator inhibitor
JP3885177B2 (ja) 1997-03-26 2007-02-21 大塚製薬株式会社 ヒト遺伝子
US6133434A (en) * 1997-04-28 2000-10-17 Glaxo Group Limited Purinergic receptor
DE19829473C2 (de) * 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Verfahren zur frühen Diagnose von Carcinomen
AUPP991199A0 (en) * 1999-04-21 1999-05-13 University Of Sydney, The Methods for diagnosing pre-cancerous and cancerous conditions
AUPR201500A0 (en) * 2000-12-11 2001-01-11 Biosceptre Pty Ltd Methods for identifying pre-neoplastic and neoplastic states in mammals
CA2434490C (en) * 2001-01-17 2014-06-03 Intreat Pty Limited Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions

Also Published As

Publication number Publication date
AU3949000A (en) 2001-02-05
US20110111431A1 (en) 2011-05-12
DK1179183T3 (da) 2010-05-25
EP1179183A4 (de) 2003-01-22
NO20015157L (no) 2001-12-21
CN1355886A (zh) 2002-06-26
ES2340137T3 (es) 2010-05-31
JP4633984B2 (ja) 2011-02-16
CN100557445C (zh) 2009-11-04
NO331018B1 (no) 2011-09-12
KR100819395B1 (ko) 2008-04-04
WO2001006259A1 (en) 2001-01-25
NO20015157D0 (no) 2001-10-22
KR20020022651A (ko) 2002-03-27
HK1044190A1 (en) 2002-10-11
AUPP991199A0 (en) 1999-05-13
ZA200108616B (en) 2002-06-13
CA2371163A1 (en) 2001-01-25
AU779845B2 (en) 2005-02-17
EP1179183B1 (de) 2010-01-27
US20070248963A1 (en) 2007-10-25
JP2003504643A (ja) 2003-02-04
US7183064B1 (en) 2007-02-27
EP1179183A1 (de) 2002-02-13
DE60043775D1 (de) 2010-03-18

Similar Documents

Publication Publication Date Title
DE60043775D1 (de) Verfahren zum identifizieren von präneoplastischen und neoplastischen stadien in säugern
ATE350131T1 (de) Verfahren zur behandlung von fluida
DE69812316D1 (de) Verfahren zum Einschneiden von bestehenden Rohrleitungen, Rohrleitungen, und Verfahren zum Einsatz von Ventilen in Rohrleitungen
DE69909702D1 (de) Verfahren zum Erhärten Stahlwerksslacke sowie damit hergestelltes Material
DE69418818D1 (de) Verfahren zur Ortung von Rohrverbindungen im Bohrloch
DE69939945D1 (de) Verfahren zur isolierung von stammzellen
DE59501767D1 (de) Vorrichtung zum Behandeln von Oberflächen, insbesondere von Innenflächen von Kraftstofftanks
ATE213005T1 (de) Kontinuierliches polymerisationverfahren von polyamiden
ATE230487T1 (de) Verfahren zur frühen diagnose von carcinomen
ATE321088T1 (de) Polysiloxanpolymere, verfahren zu ihrer herstellung und ihre verwendung
DE69823347D1 (de) Mikrofluidisches system und verfahren zu dessen betrieb
DE60107681D1 (de) Vaskuläre vorrichtung zum zusammenbringen von ventilklappen
DE69909987D1 (de) Sputtertarget, transparenter leitender film und verfahren zu dessen herstellung
DE69939312D1 (de) Verfahren zur identifizierung von induktoren und inhibitoren proteolytischer antikörper, zusammensetzungen sowie deren verwendungen
ATE190357T1 (de) Schnelles verfahren fur die dns sequenzierung und diagnostische anwendungen
DE69822348D1 (de) R. b. yun s verfahren zur ausbeutung von tagebaulagerstätten
ATE428803T1 (de) Expression von p2y-purinergem rezeptor zur identifizierung präneoplastischer und neoplastischer zustände
DE69836649D1 (de) Verfahren zum Fördern von Beuteln.
ATE391549T1 (de) Verfahren und vorrichtung zum entsalzen von wasser mit druckabfallüberbrückung
DE69615339D1 (de) Verfahren zum nachweis des endogenen thrombin-potentials und thrombin substrate zur verwendung in diesen verfahren
ATE126830T1 (de) Verfahren zum nachweis von kleinzelligem carzinom und die verwendung von sequenzen, die acylpeptid- hydrolase codieren, für diesen zweck.
DE68917154D1 (de) C-terminus-amidierungsenzym-zusammensetzung, verfahren zur herstellung und verwendung.
DE69802099D1 (de) Mikromonochromator und verfahren für dessen herstellung
DK1143917T3 (da) Antikonvulsive derivater egnet til behandling af posttraumatisk stresssygdom
DE50309796D1 (de) Verfahren zum immunzytologischen oder molekularen nachweis von disseminierten tumorzellen aus einer körperflüssigkeit und dazu geeigneter kit

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1179183

Country of ref document: EP